跳至主要内容
临床试验/NCT03326622
NCT03326622已完成不适用

The Role of Moderate Aerobic Exercise as Determined by Cardiopulmonary Exercise Testing in ALS

University of Lisbon0 个研究点目标入组 48 人开始时间: 2013年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48
主要终点
Functional decline between start and end of the study

研究概览

简要总结

This study evaluated the influence of a tailored aerobic exercise protocol on the functional outcome in ALS patients. In addition, the investigators compare some CPET variables collected during exercise testing in both groups.

详细描述

This work aimed to evaluate the effects of a moderate aerobic exercise with controlled intensity determined by Cardiopulmonary Exercise Testing (CPET) and its role on the functional status in ALS patients versus standard care. Additionally, the investigators explored the performance of CPET variables - oxygen uptake (VO2) expressed in L/min, in percentage of predicted or in metabolic equivalents (METs) at peak effort, at anaerobic threshold (AT), the respiratory compensation point (RCP) when achieved, Dioxide Carbon output in L/min (VCO2) and the minute ventilation in L/min (VE) throughout the study.

Assessments:(diagnostic visit - T0), at study entry (T1) and 6 months after (T2) using:

Functional status by Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R), Respiratory function tests (RFT): Forced Vital Capacity predicted (%FVC) and Oxygen saturation provided by pulse oximetry.

CPET was performed in both groups at study entry and 6 months later (T1 and T2), using a treadmill (WOODWAY®) coupled with a gas exchange analyzer (METALYZER® 3B) with ergo-spirometry system using a breath-by-breath technology developed by CORTEX® systems.

Intervention:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

盲法说明

single blinded

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive patients diagnosed with definite, probable, or probable laboratory supported ALS
  • Disease duration from first symptoms between 6-24 months to exclude slow and fast progression
  • ALSFRS-R ≥ 30
  • FVC (%predicted) ≥ 70%

排除标准

  • Other medical conditions, like cardiac insufficiency and lung disorders or others conditions limiting exercise training;
  • Heavy smoking habits with laboratorial evidence of significant bronchial constriction;
  • Signs of associated dementia or psychiatric disorders.
  • Note: None of the patients were on tube feeding, invasive or non-invasive mechanical ventilation at admission of study protocol (T1).

结局指标

主要结局

Functional decline between start and end of the study

时间窗: between baseline and 6 months later

It was used the Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R),which rates the functionality of the ALS patients in performing activities involving 4 different areas through 3 sub-scores - bulbar, spinal \[upper and lower limb\] and also the respiratory function. Each of its questions is rated from 0 (total inability) to 4 points (no functional limitation). The last three questions address the respiratory function (dyspnea, orthopnea, respiratory insufficiency) and assess the respiratory functional outcome. The sub-scores rating: Bulbar sub-score between 0 - 12, the spinal score between 0 - 24 and the respiratory sub-score between 0 - 12.The sum of the sub-scores provide an ALSFRS-R total score = 48. Higher values represent a better functionality.

次要结局

  • Performance of Cardiopulmonary Exercise testing variables throughout the study(at study entry and 6 months later.)
  • Changes on the Dioxide Carbon output (VCO2) measurement(at study entry and 6 months later)
  • Changes on the Minute Ventilation (VE) measurement(at study entry and 6 months later)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anna Caroline Braga

Investigator

University of Lisbon

相似试验